FDA — authorised 28 December 1988
- Application: NDA018869
- Marketing authorisation holder: BAYER PHARMS
- Local brand name: NIMOTOP
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Nimotop in United States
FDA authorised Nimotop on 28 December 1988
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Nimotop approved in United States?
Yes. FDA authorised it on 28 December 1988.
Who is the marketing authorisation holder for Nimotop in United States?
BAYER PHARMS holds the US marketing authorisation.